The North America Herpes Simplex Virus Treatment Market would witness market growth of 1.8% CAGR during the forecast period (2022-2028).
HSV-1 is mostly spread through contact with surfaces in or near the mouth, saliva, or sores that have the virus present. Less frequently, HSV-1 can spread from the mouth to the genital region and produce genital herpes. The danger of transmission is most serious when there are open sores, whether on the skin or in the mouth. HSV-1-positive individuals are not in danger of reinfection, but such individuals are still at risk of contracting HSV-2. HSV-2 is primarily spread during intercourse by contact with the anal or genital surfaces, skin, lesions, or fluids of an infected person.
HSV-2 can spread even if the skin seems normal and frequently does so without causing any symptoms. Neonatal herpes (HSV-1 & HSV-2) can, in extremely rare cases, be passed from mother to infant during birth. Currently, several herpes simplex virus control treatments are available in the market, like vaccines, pills, etc. A vaccine called SB208141 that GSK created has just finished Phase III of clinical trials.
Research and development efforts to create and offer competent and effective preventive solutions as vaccine candidates are additionally propelling the market's expansion. Also, since there is no licensed vaccine or treatment for herpes on the market, there is a greater need to produce and manufacture novel products.
Due to the rising frequency of herpes simplex virus infections, the demand for its treatment is rising in North America. Analytic Characterization of the Herpes Simplex Virus Type 2 Epidemic in the United States, 1950–2050, published in the Open Forum Infectious Diseases Journal in April 2021, claimed that over a century, the epidemic had changed significantly, having the greatest impact on people between the ages of 15 and 34. Moreover, in addition to the 47 million HSV illnesses that affected many people in 2020, there will be a high incidence during the following three decades, with more than 600,000 new infections arising each year. Therefore, the region's market is anticipated to develop due to the rising number of HSV infections.
The US market dominated the North America Herpes Simplex Virus Treatment Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $532.3 Million by 2028. The Canada market is poised to grow at a CAGR of 3.8% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 3.5% during (2022 - 2028).
Based on Drug Type, the market is segmented into Valacyclovir, Acyclovir, and Famciclovir. Based on Type, the market is segmented into Herpes simplex virus-1 Infection, and Herpes simplex virus-2 Infection. Based on Distribution Channel, the market is segmented into Drug Store & Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Herpes Simplex Virus Treatment Market is Predict to reach $2.1 Billion by 2028, at a CAGR of 3%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Pfizer, Inc., Amneal Pharmaceuticals, Inc., GlaxoSmithKline PLC, Teva Pharmaceuticals Industries Ltd., Glenmark Pharmaceuticals Limited, Fresenius SE & Co. KGaA, Novartis AG, Viatris, Inc., and Emcure Pharmaceuticals Limited.
Scope of the Study
Market Segments Covered in the Report:
By Drug Type
- Valacyclovir
- Acyclovir
- Famciclovir
By Type
- Herpes simplex virus-1 Infection
- Herpes simplex virus-2 Infection
By Distribution Channel
- Drug Store & Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Abbott Laboratories
- Pfizer, Inc.
- Amneal Pharmaceuticals, Inc.
- GlaxoSmithKline PLC
- Teva Pharmaceuticals Industries Ltd.
- Glenmark Pharmaceuticals Limited
- Fresenius SE & Co. KGaA
- Novartis AG
- Viatris, Inc.
- Emcure Pharmaceuticals Limited
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Herpes Simplex Virus Treatment Market, by Drug Type
1.4.2 North America Herpes Simplex Virus Treatment Market, by Type
1.4.3 North America Herpes Simplex Virus Treatment Market, by Distribution Channel
1.4.4 North America Herpes Simplex Virus Treatment Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Herpes Simplex Virus Treatment Market by Drug Type
3.1 North America Valacyclovir Market by Country
3.2 North America Acyclovir Market by Country
3.3 North America Famciclovir Market by Country
Chapter 4. North America Herpes Simplex Virus Treatment Market by Type
4.1 North America Herpes simplex virus-1 Infection Market by Country
4.2 North America Herpes simplex virus-2 Infection Market by Country
Chapter 5. North America Herpes Simplex Virus Treatment Market by Distribution Channel
5.1 North America Drug Store & Retail Pharmacies Market by Country
5.2 North America Hospital Pharmacies Market by Country
5.3 North America Online Pharmacies Market by Country
Chapter 6. North America Herpes Simplex Virus Treatment Market by Country
6.1 US Herpes Simplex Virus Treatment Market
6.1.1 US Herpes Simplex Virus Treatment Market by Drug Type
6.1.2 US Herpes Simplex Virus Treatment Market by Type
6.1.3 US Herpes Simplex Virus Treatment Market by Distribution Channel
6.2 Canada Herpes Simplex Virus Treatment Market
6.2.1 Canada Herpes Simplex Virus Treatment Market by Drug Type
6.2.2 Canada Herpes Simplex Virus Treatment Market by Type
6.2.3 Canada Herpes Simplex Virus Treatment Market by Distribution Channel
6.3 Mexico Herpes Simplex Virus Treatment Market
6.3.1 Mexico Herpes Simplex Virus Treatment Market by Drug Type
6.3.2 Mexico Herpes Simplex Virus Treatment Market by Type
6.3.3 Mexico Herpes Simplex Virus Treatment Market by Distribution Channel
6.4 Rest of North America Herpes Simplex Virus Treatment Market
6.4.1 Rest of North America Herpes Simplex Virus Treatment Market by Drug Type
6.4.2 Rest of North America Herpes Simplex Virus Treatment Market by Type
6.4.3 Rest of North America Herpes Simplex Virus Treatment Market by Distribution Channel
Chapter 7. Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 SWOT Analysis
7.2 Pfizer, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional & Segmental Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Partnerships, Collaborations, and Agreements:
7.3 Amneal Pharmaceuticals, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental Analysis
7.3.4 Research & Development Expenses
7.3.5 Recent strategies and developments:
7.3.5.1 Approvals and Trials:
7.4 GlaxoSmithKline PLC (GSK)
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Approvals and Trials:
7.5 Teva Pharmaceutical Industries Ltd.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional Analysis
7.5.4 Research & Development Expenses
7.6 Glenmark Pharmaceuticals Limited
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Regional Analysis
7.6.4 Research & Development Expenses
7.7 Fresenius SE & Co. KGaA
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expenses
7.8 Novartis AG
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.9 Viatris, Inc.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental Analysis
7.9.4 Research & Development Expense
7.10. Emcure Pharmaceuticals Limited
7.10.1 Company Overview
TABLE 1 North America Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
TABLE 2 North America Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
TABLE 3 North America Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 4 North America Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 5 North America Valacyclovir Market by Country, 2018 - 2021, USD Million
TABLE 6 North America Valacyclovir Market by Country, 2022 - 2028, USD Million
TABLE 7 North America Acyclovir Market by Country, 2018 - 2021, USD Million
TABLE 8 North America Acyclovir Market by Country, 2022 - 2028, USD Million
TABLE 9 North America Famciclovir Market by Country, 2018 - 2021, USD Million
TABLE 10 North America Famciclovir Market by Country, 2022 - 2028, USD Million
TABLE 11 North America Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
TABLE 12 North America Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
TABLE 13 North America Herpes simplex virus-1 Infection Market by Country, 2018 - 2021, USD Million
TABLE 14 North America Herpes simplex virus-1 Infection Market by Country, 2022 - 2028, USD Million
TABLE 15 North America Herpes simplex virus-2 Infection Market by Country, 2018 - 2021, USD Million
TABLE 16 North America Herpes simplex virus-2 Infection Market by Country, 2022 - 2028, USD Million
TABLE 17 North America Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 18 North America Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 19 North America Drug Store & Retail Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 20 North America Drug Store & Retail Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 21 North America Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 22 North America Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 23 North America Online Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 24 North America Online Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 25 North America Herpes Simplex Virus Treatment Market by Country, 2018 - 2021, USD Million
TABLE 26 North America Herpes Simplex Virus Treatment Market by Country, 2022 - 2028, USD Million
TABLE 27 US Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
TABLE 28 US Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
TABLE 29 US Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 30 US Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 31 US Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
TABLE 32 US Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
TABLE 33 US Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 34 US Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 35 Canada Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
TABLE 36 Canada Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
TABLE 37 Canada Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 38 Canada Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 39 Canada Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
TABLE 40 Canada Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
TABLE 41 Canada Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 42 Canada Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 43 Mexico Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
TABLE 44 Mexico Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
TABLE 45 Mexico Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 46 Mexico Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 47 Mexico Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
TABLE 48 Mexico Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
TABLE 49 Mexico Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 50 Mexico Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 51 Rest of North America Herpes Simplex Virus Treatment Market, 2018 - 2021, USD Million
TABLE 52 Rest of North America Herpes Simplex Virus Treatment Market, 2022 - 2028, USD Million
TABLE 53 Rest of North America Herpes Simplex Virus Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 54 Rest of North America Herpes Simplex Virus Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 55 Rest of North America Herpes Simplex Virus Treatment Market by Type, 2018 - 2021, USD Million
TABLE 56 Rest of North America Herpes Simplex Virus Treatment Market by Type, 2022 - 2028, USD Million
TABLE 57 Rest of North America Herpes Simplex Virus Treatment Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 58 Rest of North America Herpes Simplex Virus Treatment Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 59 Key Information – Abbott Laboratories
TABLE 60 Key Information – Pfizer, Inc.
TABLE 61 Key Information – Amneal Pharmaceuticals, INc.
TABLE 62 Key Information – GlaxoSmithKline PLC
TABLE 63 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 64 Key Information – Glenmark Pharmaceuticals Limited
TABLE 65 key information – Fresenius SE & Co. KGaA
TABLE 66 Key Information – Novartis AG
TABLE 67 key information – Viatris, Inc.
TABLE 68 Key Information – Emcure Pharmaceuticals Limited
List of Figures
FIG 1 Methodology for the research
FIG 2 Swot analysis: Abbott laboratories